Engineering the Regioselectivity of Cyclododecanone Monooxygenase Público

Keshavarz-Joud, Parisa (Spring 2018)

Permanent URL: https://etd.library.emory.edu/concern/etds/g158bh30q?locale=es
Published

Abstract

Baeyer-Villiger monooxygenases (BVMOs) are the enzymatic alternatives to the chemical Baeyer-Villiger oxidation reaction. The regioselectivity of these enzymes is mostly dependent upon active site residues that govern the stability of the Criegee intermediate and the preferred migratory group of the substrate. The BVMO of interest in this work is cyclododecanone monooxygenase from Rhodococcus ruber SC1 (CDMO). We aim to achieve higher regioselectivity towards two substrates, methyl (2-methyl-6-oxooctan-4-yl) carbamate and 3-methylcyclohexanone. The unnatural product formed as the result of Baeyer-Villiger oxidation with methyl (2-methyl-6-oxooctan-4-yl) carbamate is a -amino acid ester, which after hydrolysis yields useful building blocks for the production of β-peptides, alkaloids, and β-lactam antibiotics. As indicated in literature sources, the conserved arginine-interacting loop in the structure of some BVMOs plays an important role in directing product regioselectivity. We were able to increase the size of the CDMO active site via rational engineering by truncating amino acid side chains on the above-mentioned loop. Here we introduce novel variants with increased activity and regioselectivity towards methyl (2-methyl-6-oxooctan-4-yl) carbamate that also form the unnatural product. Furthermore, we demonstrated that the observed change in regioselectivity does not apply universally, as seen with 3-methylcyclohexanone. Neither of the constructed variants showed promising conversion rates or increased regioselectivity towards 3-methylcyclohexanone and it is potentially due to its small size compared to methyl (2-methyl-6-oxooctan-4-yl) carbamate.    

Table of Contents

1.         Introduction………………………………………....................................….…1

1.1.      Baeyer-Villiger Oxidation…………………….…..............................……..1

1.2.      Baeyer Villiger Monooxygenases (BVMOs)…….......................….….4

1.2.1.   Arginine-Interacting Loop……………………….............................……..6

1.2.2.   Cyclododecanone Monooxygenase………….…..........................………7

2.         Materials and Methods……………………….............................………...11

2.1.      Cloning………………………………………….....................................……...11

2.2.      Expression…………………………………………....................................…..12

2.3.      Purification……………………………….....................................…………….13

2.4.      Activity Assay ………………………....................................…………………14

2.5.      GC Protocol………………………………......................................……………15

2.6.      GCMS Protocol……………………….....................................………………..15

3.         Results and Discussion………………………………..................................16

3.1.      Loop Mutations………………………...................................………………...16

3.2.      Variants P190I/A498G and P190I/L499G……........................….…….21

4.         Conclusion…………………………………………..........................................27

5.         References……………………………………….....................................……...29

About this Honors Thesis

Rights statement
  • Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.
School
Department
Degree
Submission
Language
  • English
Research Field
Palabra Clave
Committee Chair / Thesis Advisor
Committee Members
Última modificación

Primary PDF

Supplemental Files